StockMarketWire.com - Oncology, inflammation and infectious diseases focused Tiziana Life Sciences said it had appointed Neil Graham as its chief medical officer.

Graham had from 2010 to 2020 been vice-president of strategic program direction, immunology and inflammation at Regeneron Pharmaceuticals.


At 9:11am: [LON:TILS] Tiziana Life Sciences Plc share price was 0p at 92p



Story provided by StockMarketWire.com